Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome
- PMID: 35166384
- DOI: 10.1111/apt.16812
Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome
Abstract
Background: FODMAPs produce similar small bowel water and colonic gas in patients with irritable bowel syndrome (IBS) and healthy controls (HCs), despite IBS patients reporting increased gastrointestinal (GI) symptoms.
Aim: To unravel the mechanisms underlying FODMAP-induced symptom reporting, we investigated gut and brain responses to fructan administration in IBS patients and HC.
Methods: This randomised, double-blind, cross-over study consisted of three visits where fructans (40 g/500 mL saline), glucose (40 g/500 mL saline) or saline (500 mL) were infused intragastrically during 1 h MR brain scanning; abdominal MRI was performed before, 1 h, and 2 h post-infusion. Symptoms were rated using validated scales.
Results: In IBS (n = 13), fructans induced more cramps, pain, flatulence and nausea compared to glucose (P = 0.03, 0.001, 0.009 and <0.001 respectively), contrary to HC (n = 13) (all P > 0.14), with between-group differences for cramps and nausea (P = 0.004 and 0.023). Fructans increased small bowel motility and ascending colonic gas and volume equally in IBS and HC (between-group P > 0.25). The difference in colonic gas between fructans and saline covaried with differences in bloating and cramps in IBS (P = 0.008 and 0.035 respectively). Pain-related brain regions responded differentially to fructans in IBS compared to HC, including the cerebellum, supramarginal gyrus, anterior and midcingulate cortex, insula and thalamus (pFWE-corrected < 0.05); these brain responses covaried with symptom responses in IBS.
Conclusions: Fructans increase small bowel motility and colon gas and volume similarly in IBS patients and HC. Increased symptom responses to fructans in IBS covary with altered brain responses in pain-related regions, indicating that gut-brain axis dysregulation may drive FODMAP-induced symptom generation in IBS.
Trial registration: ClinicalTrials.gov NCT04283487.
Keywords: FODMAP; abdominal imaging; irritable bowel syndrome.
© 2022 John Wiley & Sons Ltd.
Comment in
-
Editorial: meal-induced symptoms in irritable bowel syndrome-"all in the mind"?Aliment Pharmacol Ther. 2022 Apr;55(7):880-881. doi: 10.1111/apt.16858. Aliment Pharmacol Ther. 2022. PMID: 35315103 No abstract available.
-
Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs.Aliment Pharmacol Ther. 2022 Jul;56(2):366-367. doi: 10.1111/apt.16975. Aliment Pharmacol Ther. 2022. PMID: 35748832 No abstract available.
-
Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs. Authors' reply.Aliment Pharmacol Ther. 2022 Jul;56(2):368-369. doi: 10.1111/apt.17074. Aliment Pharmacol Ther. 2022. PMID: 35748835 No abstract available.
References
REFERENCES
-
- Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396:1675-1688.
-
- Simren M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol. 2018;15:589-605.
-
- Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2021. doi: 10.1136/gutjnl-2021-325214
-
- Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66:1517-1527.
-
- Major G, Pritchard S, Murray K, et al. Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome. Gastroenterology. 2017;152:124-133.e2.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical